Needham cuts Revolution shares target, keeps buy rating on positive outlook
RVMD Stock | USD 43.77 0.48 1.11% |
About 66% of Revolution Medicines' investor base is looking to short. The analysis of the overall investor sentiment regarding Revolution Medicines suggests that many traders are alarmed. The current market sentiment, together with Revolution Medicines' historical and current headlines, can help investors time the market. In addition, many technical investors use Revolution Medicines stock news signals to limit their universe of possible portfolio assets.
Revolution |
Needham cuts Revolution shares target, keeps buy rating on positive outlook
Read at investing.com
Revolution Medicines Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Revolution Medicines can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Revolution Medicines Fundamental Analysis
We analyze Revolution Medicines' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Revolution Medicines using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Revolution Medicines based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Cash Flow From Operations
Cash Flow From Operations Comparative Analysis
Revolution Medicines is currently under evaluation in cash flow from operations category among its peers. Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
Revolution Medicines Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Revolution Medicines stock to make a market-neutral strategy. Peer analysis of Revolution Medicines could also be used in its relative valuation, which is a method of valuing Revolution Medicines by comparing valuation metrics with similar companies.
Peers
Revolution Medicines Related Equities
CCCC | C4 Therapeutics | 7.92 | ||||
AKRO | Akero Therapeutics | 3.80 | ||||
STOK | Stoke Therapeutics | 1.71 | ||||
RNA | Avidity Biosciences | 1.14 | ||||
BPMC | Blueprint Medicines | 1.01 | ||||
PTGX | Protagonist Therapeutics | 0.00 | ||||
NRIX | Nurix Therapeutics | 4.44 | ||||
BDTX | Black Diamond | 6.40 | ||||
GLUE | Monte Rosa | 7.40 | ||||
KYMR | Kymera Therapeutics | 7.66 | ||||
AGIO | Agios Pharm | 8.23 | ||||
PASG | Passage Bio | 8.96 | ||||
SANA | Sana Biotechnology | 11.52 |
Complementary Tools for Revolution Stock analysis
When running Revolution Medicines' price analysis, check to measure Revolution Medicines' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Revolution Medicines is operating at the current time. Most of Revolution Medicines' value examination focuses on studying past and present price action to predict the probability of Revolution Medicines' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Revolution Medicines' price. Additionally, you may evaluate how the addition of Revolution Medicines to your portfolios can decrease your overall portfolio volatility.
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |